CLINICAL STUDIES
Primary angioplasty versus systemic thrombolysis in anterior myocardial infarction
Eulogio García, MDa,
Jaime Elízaga, MDa,
Nicasio Pérez-Castellano, MDa,
Jose A. Serrano, MDa,
Javier Soriano, MDa,
Manuel Abeytua, MDa,
Javier Botas, MDa,
Rafael Rubio, MDa,
Esteban López de Sá, MDa,
Jose L. López-Sendón, MD, FACCa and
Juan L. Delcán, MDa
a Unit of Interventional Cardiology, Division of Cardiology, "Gregorio Marañón" University General Hospital, Madrid, Spain
Manuscript received March 3, 1998;
revised manuscript received September 21, 1998,
accepted November 2, 1998.
Reprint requests and correspondence: Dr. Eulogio García, Sección de Hemodinámica, Servicio de Cardiología, Hospital General Universitario "Gregorio Marañón", C/Doctor Esquerdo 46, 28007 Madrid, Spain
OBJECTIVES
This study compares the efficacy of primary angioplasty and systemic thrombolysis with t-PA in reducing the in-hospital mortality of patients with anterior AMI.
BACKGROUND
Controversy still exists about the relative benefit of primary angioplasty over thrombolysis as treatment for AMI.
METHODS
Two-hundred and twenty patients with anterior AMI were randomly assigned in our institution to primary angioplasty (109 patients) or systemic thrombolysis with accelerated t-PA (111 patients) within the first five hours from the onset of symptoms.
RESULTS
Baseline characteristics were similar in both groups. Primary angioplasty was independently associated with a lower in-hospital mortality (2.8% vs. 10.8%, p = 0.02, adjusted odds ratio 0.23, 95% confidence interval 0.06 to 0.85). During hospitalization, patients treated by angioplasty had a lower frequency of postinfarction angina or positive stress test (11.9% vs. 25.2%, p = 0.01) and less frequently underwent percutaneous or surgical revascularization after the initial treatment (22.0% vs. 47.7%, p < 0.001) than did patients treated by t-PA. At six month follow-up, patients treated by angioplasty had a lower cumulative rate of death (4.6% vs. 11.7%, p = 0.05) and revascularization (31.2% vs. 55.9%, p < 0.001) than those treated by t-PA.
CONCLUSIONS
In centers with an experienced and readily available interventional team, primary angioplasty is superior to t-PA for the treatment of anterior AMI.
|
Abbreviations and Acronyms
| | AMI | = acute myocardial infarction | | CABG | = coronary artery bypass graft surgery | | CK-MB | = MB fraction of creatine kinase | | LAD | = left anterior descending coronary artery | | PTCA | = percutaneous transluminal coronary angioplasty | | t-PA | = tissue plasminogen activator |
|
This article has been cited by other articles:

|
 |

|
 |
 
T. Huynh, S. Perron, J. O'Loughlin, L. Joseph, M. Labrecque, J. V. Tu, and P. Theroux
Comparison of Primary Percutaneous Coronary Intervention and Fibrinolytic Therapy in ST-Segment-Elevation Myocardial Infarction: Bayesian Hierarchical Meta-Analyses of Randomized Controlled Trials and Observational Studies
Circulation,
June 23, 2009;
119(24):
3101 - 3109.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C J Terkelsen, E H Christiansen, J T Sorensen, S D Kristensen, J F Lassen, L Thuesen, H R Andersen, W Vach, and T T Nielsen
Primary PCI as the preferred reperfusion therapy in STEMI: it is a matter of time
Heart,
March 1, 2009;
95(5):
362 - 369.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. J. Terkelsen and T. T. Nielsen
Reperfusion Strategies in Acute ST-Segment Elevation Myocardial Infarction: Acute Angioplasty May Be Feasible for the Majority of U.S. Citizens
J. Am. Coll. Cardiol.,
September 9, 2008;
52(11):
966 - 967.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Asseburg, Y. Bravo Vergel, S. Palmer, E. Fenwick, M. de Belder, K. R Abrams, and M. Sculpher
Assessing the effectiveness of primary angioplasty compared with thrombolysis and its relationship to time delay: a Bayesian evidence synthesis
Heart,
October 1, 2007;
93(10):
1244 - 1250.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. E. Boden, K. Eagle, and C. B. Granger
Reperfusion Strategies in Acute ST-Segment Elevation Myocardial Infarction: A Comprehensive Review of Contemporary Management Options
J. Am. Coll. Cardiol.,
September 4, 2007;
50(10):
917 - 929.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. R. Timmer, J. P. Ottervanger, M.-J. de Boer, E. Boersma, C. L. Grines, C. M. Westerhout, R. J. Simes, C. B. Granger, F. Zijlstra, and for the Primary Coronary Angioplasty vs Thrombolys
Primary Percutaneous Coronary Intervention Compared With Fibrinolysis for Myocardial Infarction in Diabetes Mellitus: Results From the Primary Coronary Angioplasty vs Thrombolysis-2 Trial
Arch Intern Med,
July 9, 2007;
167(13):
1353 - 1359.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. S. Hollenbeak, J. P. Fitzgibbons, M. Rossi, D. L. Morris, and P. Stillman
The Impact of Percutaneous Coronary Interventions on Outcomes for Acute Myocardial Infarction in Pennsylvania
American Journal of Medical Quality,
March 1, 2007;
22(2):
85 - 94.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
H. H. Ting, E. H. Yang, and C. S. Rihal
Narrative review: reperfusion strategies for ST-segment elevation myocardial infarction.
Ann Intern Med,
October 17, 2006;
145(8):
610 - 617.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Boersma and The Primary Coronary Angioplasty vs. Thrombolysis
Does time matter? A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction patients
Eur. Heart J.,
April 1, 2006;
27(7):
779 - 788.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Part 5: Acute Coronary Syndromes
Circulation,
November 29, 2005;
112(22_suppl):
III-55 - III-72.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Huber, R. D. Caterina, S. D. Kristensen, F. W.A. Verheugt, G. Montalescot, L. B. Maestro, F. V. d. Werf, and for the Task Force on Pre-hospital Reperfusion The
Pre-hospital reperfusion therapy: a strategy to improve therapeutic outcome in patients with ST-elevation myocardial infarction
Eur. Heart J.,
October 1, 2005;
26(19):
2063 - 2074.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. R. Le May, G. A. Wells, M. Labinaz, R. F. Davies, M. Turek, D. Leddy, J. Maloney, T. McKibbin, B. Quinn, R. S. Beanlands, et al.
Combined Angioplasty and Pharmacological Intervention Versus Thrombolysis Alone in Acute Myocardial Infarction (CAPITAL AMI Study)
J. Am. Coll. Cardiol.,
August 2, 2005;
46(3):
417 - 424.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Writing Committee Members, E. M. Antman, D. T. Anbe, P. W. Armstrong, E. R. Bates, L. A. Green, M. Hand, J. S. Hochman, H. M. Krumholz, F. G. Kushner, et al.
ACC/AHA guidelines for the management of patients with ST-Elevation myocardial infarction--executive summary: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (writing committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction)
J. Am. Coll. Cardiol.,
August 4, 2004;
44(3):
671 - 719.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. M. Antman, D. T. Anbe, P. W. Armstrong, E. R. Bates, L. A. Green, M. Hand, J. S. Hochman, H. M. Krumholz, F. G. Kushner, G. A. Lamas, et al.
ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction--Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction)
Circulation,
August 3, 2004;
110(5):
588 - 636.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. A. Kloner and S. H. Rezkalla
Cardiac protection during acute myocardial infarction: Where do we stand in 2004?
J. Am. Coll. Cardiol.,
July 21, 2004;
44(2):
276 - 286.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Smith
Primary angioplasty should be first line treatment for acute myocardial infarction: FOR
BMJ,
May 22, 2004;
328(7450):
1254 - 1256.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. R. Le May, R. F. Davies, M. Labinaz, H. Sherrard, J.-F. Marquis, L. A. Laramee, E. R. O'Brien, W. L. Williams, R. S. Beanlands, G. Nichol, et al.
Hospitalization Costs of Primary Stenting Versus Thrombolysis in Acute Myocardial Infarction: Cost Analysis of the Canadian STAT Study
Circulation,
November 25, 2003;
108(21):
2624 - 2630.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J Hilden and A Gammelgaard
Premature stopping and informed consent in AMI trials
J. Med. Ethics,
June 1, 2002;
28(3):
188 - 189.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F Zijlstra, A Patel, M Jones, C.L Grines, S Ellis, E Garcia, L Grinfeld, R.J Gibbons, E.E Ribeiro, F Ribichini, et al.
Clinical characteristics and outcome of patients with early (<2h), intermediate (2-4h) and late (>4h) presentation treated by primary coronary angioplasty or thrombolytic therapy for acute myocardial infarction
Eur. Heart J.,
April 1, 2002;
23(7):
550 - 557.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Moreno, J. Lopez-Sendon, E. Garcia, L. P.e. de Isla, E. L.o. de Sa, A. Ortega, M. Moreno, R. Rubio, J. Soriano, M. Abeytua, et al.
Primary angioplasty reduces the risk of left ventricular free wall rupture compared with thrombolysis in patients with acute myocardial infarction
J. Am. Coll. Cardiol.,
February 20, 2002;
39(4):
598 - 603.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Zahn, R. Schiele, S. Schneider, A. K. Gitt, H. Wienbergen, K. Seidl, T. Voigtlander, M. Gottwik, G. Berg, E. Altmann, et al.
Primary angioplasty versus intravenous thrombolysis in acute myocardial infarction: can we define subgroups of patients benefiting most from primary angioplasty?: Results from the pooled data of the maximal individual therapy in acute myocardial infarction registry and the myocardial infarction registry
J. Am. Coll. Cardiol.,
June 1, 2001;
37(7):
1827 - 1835.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Verdu-Pascual and A. Castello-Ponce
Randomised clinical trials: a source of ethical dilemmas
J. Med. Ethics,
June 1, 2001;
27(3):
177 - 178.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. R. Le May, M. Labinaz, R. F. Davies, J.-F. Marquis, L. A. Laramee, E. R. O'Brien, W. L. Williams, R. S. Beanlands, G. Nichol, and L. A. Higginson
Stenting versus thrombolysis in acute myocardial infarction trial (STAT)
J. Am. Coll. Cardiol.,
March 15, 2001;
37(4):
985 - 991.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. L. Hannan, M. J. Racz, D. T. Arani, T. J. Ryan, G. Walford, and B. D. McCallister
Short- and long-term mortality for patients undergoing primary angioplasty for acute myocardial infarction
J. Am. Coll. Cardiol.,
October 1, 2000;
36(4):
1194 - 1201.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. P. Wharton Jr., N. Sinclair McNamara, F. A. Fedele, M. I. Jacobs, A. R. Gladstone, and E. J. Funk
Reply
J. Am. Coll. Cardiol.,
July 1, 2000;
36(1):
301 - 303.
[Full Text]
[PDF]
|
 |
|
|